Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2023/10/058292
CTRI/2023/10/058292
Not yet recruiting
未知

Investigating the Immunotherapeutic potential of invariant natural killerT cells (iNKT) cells in Triple negative Breast cancer (TNBC) - Nil

Tata Memorial Center0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: C509- Malignant neoplasm of breast of unspecified site

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
Sponsor
Tata Memorial Center
Status
Not yet recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Tata Memorial Center

Eligibility Criteria

Inclusion Criteria

  • •Adult Patients with early\-stage breast cancer undergoing biopsy if age less than 50 years.
  • •Adult Patients 18\-65 years of age with metastatic breast cancer that is histologically proven to be
  • •triple negative.
  • •Adult Patients with early\-stage breast cancer undergoing biopsy if age less than 50 years.

Exclusion Criteria

  • •1\. Patients with hormone receptor positive or HER 2 positive breast cancer
  • •2\. Patients who had received two or more lines of chemotherapy in
  • •metastatic setting

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
Potentiating clinical and immunological effects of chemotherapy by neutralizing acidic pH at tumor site: a phase II randomized study in melanoma patientsMetastatic Cutaneous and Subcutaneous MelanomaMedDRA version: 15.0Level: LLTClassification code 10027481Term: Metastatic melanomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]
EUCTR2012-002059-40-ITISTITUTO NAZIONALE PER LA CURA TUMORI
Completed
Phase 2
To study the effect of Swarnaprashan in reducing the frequency of illness in children by improving the immunity and increasing the body strength.
CTRI/2021/05/033713ational Institute of Ayurveda Jaipur Rajasthan30
Unknown
Not Applicable
Feasibility 'innate' allogeneic stem cells transplantioHematological malignancies (hematologische maligniteiten)Allogeneic stem cells transplantation (allogene stamcel transplantatie)Innate immune system (aangeboren immuunsysteem)
NL-OMON25484MC UtrechtHeidelberglaan 1003584 CX Utrecht35
Not yet recruiting
Not Applicable
Investigate the safety and efficacy of small cell lung cancer,Kidney cancer and Primary liver cancer immunotherapyHistopathologically confirmed small cell lung cancer (SCLC)Histopathologically confirmed Kidney cancerHistopathologically confirmed Liver cancer
ACTRN12618001337268The First Teaching Hospital, Inner Mongolia Medical University50
Not yet recruiting
Phase 2
Rasayana effects of Ashwagandha and Guduchi in Healthy Volunteers
CTRI/2024/01/061852Institute of Teaching and Research in Ayurveda, Jamnagar 361008, Gujarat, India